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Abbreviations: CI = confidence interval, CNS = central nervous system, Cr = creatinine, CVS = 
cardiovascular system, ED = emergency department, FiO2 = fraction inspired oxygen, GCS = Glascow 
coma score, GIT = gastrointestinal system, HAEM = haematological system, HR = hazard ratio, ICU = 
intensive care unit, IQR = inter-quartile range, NA = noradrenaline, OR = odds ratio, PaO2 = arterial 
oxygen partial pressure (mmHg), RA = room air, RESP = respiratory system, RR = relative risk, SBP = 
systolic blood pressure, SD = standard deviation, SIRS = systemic inflammatory response syndrome, 
SOFA = sequential organ function assessment, SpO2 = oximetry saturation, UO = urine output. 
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ABSTRACT 
 
Objective: A proposed revision of sepsis definitions has abandoned SIRS, defined organ dysfunction 
as an increase in total SOFA score of ≥2, and conceived “qSOFA” as a bedside indicator of organ 
dysfunction. We aimed to (1) determine the prognostic impact of SIRS, (2) compare diagnostic 
accuracy of SIRS and qSOFA for organ dysfunction, and (3) compare standard (Sepsis-2) and revised 
(Sepsis-3) definitions for organ dysfunction in emergency department patients with infection. 
 
Methods: Consecutive ED patients admitted with presumed infection were prospectively enrolled 
over three years. Observational data were collected sufficient to calculate SIRS, qSOFA, SOFA, 
comorbidity and mortality. 
 
Results: 8871 patients were enrolled, 4176 (47.1%) with SIRS. SIRS was associated with increased 
risk of organ dysfunction (RR 3.5), and mortality in patients without organ dysfunction (OR 3.2). SIRS 
and qSOFA showed similar discrimination for organ dysfunction (AUROC 0.72 vs 0.73). qSOFA was 
specific but poorly sensitive for organ dysfunction (96.1%, 29.7% respectively). Mortality for patients 
with organ dysfunction was similar for Sepsis-2 and Sepsis-3 (12.5%, 11.4%) although 29% of 
patients with Sepsis-3 organ dysfunction did not meet Sepsis-2 criteria. Increasing number of Sepsis-
2 organ dysfunctions was associated with greater mortality.  
   
Conclusions: SIRS was associated with organ dysfunction and mortality, and abandoning the concept 
appears premature. Although qSOFA≥2 showed high specificity, poor sensitivity may limit utility as a 
bedside screen. Although mortality for organ dysfunction was comparable between Sepsis-2 and 
Sepsis-3, more prognostic and clinical information is conveyed using Sepsis-2 regarding number of 
organ dysfunctions. The SOFA score may require recalibration. 
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INTRODUCTION 
Infectious diseases have plagued mankind for millennia,
1
 and remain a major cause of morbidity and 
mortality.
2
 Despite this, the complex pathophysiological response to infection remains to be fully 
elucidated, and a gold-standard test for serious infection (or colloquially, ‘sepsis’) does not currently 
exist. In the absence of a gold-standard test, several groups have attempted to provide clinical 
criteria for the identification of infected patients at risk of significant mortality. 
 
Consensus conferences in 1991
3
 and 2001
4
 proposed sepsis be defined as infection with systemic 
inflammatory response syndrome (SIRS), and severe sepsis as sepsis with consequent organ 
dysfunction. The sequential organ function assessment (SOFA)
5
 score was a suggested means to 
quantify dysfunction in each of six organ systems. Within this framework, sepsis research has 
advanced with promulgation of evidence-based guidelines for sepsis management,
6
 and  global 
sepsis mortality has been reduced.
7
 A recently proposed revision of sepsis definitions (“Sepsis-3”)
8
 
has discarded SIRS, with concerns that most patients with SIRS do not have infection,
9
 and that SIRS 
is absent in some critical care patients with infection.
10
 Sepsis-3 has also redefined organ dysfunction 
as an increase in total SOFA score of two or more, rather than the previous convention of using 
specified criteria to determine dysfunction in each of several organ systems. A new construct, 
“qSOFA”, has also been introduced in Sepsis-3 as a means to screen for organ dysfunction at the 
bedside using respiratory rate, blood pressure, and conscious state. 
 
However, the original definitions intended SIRS be regarded as a potential severity indicator in 
patients with suspected infection, rather than a screening test for infection. In the intensive care 
unit (ICU), SIRS is common
11
 and contributes minimally to mortality risk.
12
 As noted in a recent 
editorial critical of the revised definitions,
13
 SIRS is more likely to be useful in the Emergency 
Department (ED), where patients with infection are common and a parsimonious means to screen 
for those at higher risk of mortality is required. There are few studies specifically examining the 
prognostic utility of SIRS in ED patients with infection, and the SOFA and qSOFA scores remain to be 
evaluated in those patients. The purpose of this study was to determine in ED patients with 
suspected infection: (1) the prevalence and prognostic impact of SIRS, (2) the diagnostic accuracy of 
SIRS and qSOFA for organ dysfunction, and (3) the characteristics and utility of the current (“Sepsis-
2”) and proposed (“Sepsis-3”) SOFA-based organ dysfunction criteria. 
 
METHODS 
Study design and setting:  
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The prospective, observational database used for this study was designed to examine the 
performance of SIRS and SOFA-based organ dysfunction as originally described for Sepsis-2. 
Following the recent publication of the proposed Sepsis-3 definitions, the study scope was expanded 
retrospectively to include analysis of the new definitions. The study was undertaken in the ED of a 
tertiary, university-affiliated Australian hospital with annual census over 72,000 adult presentations. 
Data were collected over two discrete time periods, October 2007 – December 2008 (unfunded 
pilot), and June 2009 – May 2011 (funded period), totalling 160 weeks. The Royal Brisbane and 
Women’s Hospital Human Research Ethics Committee approved the study (HREC/09/QRBW/226) 
and determined patient consent not required.  
 
Participants, methods and measurements:  
Methods have been described in detail
14
 but are briefly summarized here. On a daily basis, ED 
patients admitted with a diagnosis indicating presumed or potential infection were identified. The 
charts of those patients were examined by trained data collectors. Patients were enrolled if the ED 
and admitting medical staff both indicated infection was the most likely reason for admission. 
Patients transferred from other hospitals or aged less than 17 years were not enrolled. 
 
Data were abstracted from the paper chart at the time of each patient’s enrolment, including 
physiological measurements and treatment in the ED, presumed source of infection, and co-
morbidities. At a later time, results of haematology and biochemistry tests were obtained from 
computerised hospital databases. Data were entered into a Microsoft Access (Redmond, WA) 
database and stored on a password-protected secure hospital drive. Regular automated checks for 
out-of-range entries were conducted, and the principal investigator reviewed accuracy of the data 
for all patients. The database was designed to comply with the components of the Strengthening the 
Reporting of Observational studies in Epidemiology (STROBE) statement. 
 
For each physiological parameter, the most abnormal measurement in ED was recorded. SIRS was 
defined as two or more of: heart rate >90 minute
-1
, respiratory rate >20 minute
-1
 or arterial carbon 
dioxide pressure <32 mmHg, leucocyte count >12,000 or <4,000 microlitre
-1
 and temperature <36 or 
≥38 degrees Celsius. The recorded components of qSOFA were respiratory rate ≥22 minute
-1
, systolic 
blood pressure ≤100 mmHg, and Glasgow Coma Score (GCS) ≤13. Organ function was assessed using 
a modified SOFA score (e-Table 1). Hospital records relating to previous admissions, outpatient and 
ED encounters were used to assess and record baseline organ function, which was assumed normal 
in the absence of such data. Consistent with definitions in place during data collection (Sepsis-2), 
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acute organ dysfunction was defined for primary analyses as an increase in SOFA score of two or 
more in any discrete organ system. For comparison, the proposed new definition of acute organ 
dysfunction (Sepsis-3) was an increase in total SOFA score of two or more. Shock was defined as 
hypotension (systolic blood pressure less than 90mmHg) persisting despite at least 1000mL fluid 
bolus or vasopressor infusion in the ED (corresponding to a cardiovascular SOFA score of two or 
more). The Charlson Score
15
 was calculated to quantify co-morbidity. The primary outcome measure 
was 30-day mortality, and the secondary outcome was one-year mortality. Both were obtained from 
a national deaths registry. 
 
Analysis:  
Analyses were performed using Stata version 14 (StataCorp, 2015, College Station, TX). In cases of 
readmission within 90 days, a single representative admission was selected at random from within 
that period for inclusion in the study dataset. Baseline characteristics of the study sample were 
reported by vital status at 30 days. Risk ratios and risk differences (with 95% confidence intervals) 
were calculated to identify the prognostic utility of SIRS for mortality in patients with and without 
organ dysfunction. Odds ratios adjusted for age and comorbidity also were reported. Due to the 
nonlinear relationship between age and mortality, age was stratified into 10-year categories for 
computation of adjusted odds ratios. The Charlson comorbidity index was stratified into 0, 1-2, 3-4 
and ≥5 as originally described.
15
  
 
Discrimination of SIRS and qSOFA scores for organ dysfunction and mortality was quantified using 
receiver operating curves. Sensitivity and specificity corresponding to SIRS≥2 and qSOFA≥2 were 
reported. Adjusted odds ratios for mortality were calculated for each of the SIRS and qSOFA criteria, 
each individual (Sepsis-2) organ system dysfunction, Sepsis-2 and Sepsis-3 organ dysfunction, and 
cumulative (Sepis-2) organ dysfunctions. 
 
A number of sensitivity analyses were conducted. First, analyses were repeated using multiple 
imputation of missing data to identify whether the assumption of normality in the primary analysis 
resulted in biased estimates. This resulted in imputation for 21 (0.2%) patients with missing white 
cell count and 242 (2.7%) patients with any missing SOFA score component. Analyses conducted 
using multiple imputation yielded similar estimates so were not reported. Second, to inform 
discussion regarding definitions of acute organ dysfunction, mortality was computed for different 
SOFA score thresholds.  
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RESULTS 
Patient recruitment and classification into groups according to SIRS and organ dysfunction is 
outlined in Figure 1. The study cohort comprised 8871 admissions with presumed infection over the 
total study duration of 160 weeks, after exclusion of 846 readmissions within 90 days. Numbers and 
characteristics of included and excluded representations are detailed in e-Table 2. Table 1 details 
characteristics of the study cohort. SIRS was present in 4176 (47.1%) patients and the prevalence of 
acute organ dysfunction varied according to definition (Sepsis-2: 1534 [17.3%], Sepsis-3: 2166 
[24.4%]) (Table 1). However mortality associated with organ dysfunction using Sepsis-2 and Sepsis-3 
was similar at 30 days (12.5% [95%CI 10.8-14.2%], 11.4% [95%CI 10.1-12.8%] difference 1.0% [95%CI 
-1.1-3.2%]) and at one year (25.5% [95%CI 23.3-27.7%], 26.3% [95%CI 24.4-28.2%], difference 0.8% 
[95%CI -2.1-3.6%]). 
 
Table 2 compares the prevalence and prognostic implications of SIRS in subgroups with and without 
organ dysfunction, and with shock. In the overall cohort, SIRS was associated with increased risk of 
(Sepsis-2) organ dysfunction (RR 3.5, 95%CI 3.1-3.8), and increased odds of mortality in patients 
without (Sepsis-2) organ dysfunction (OR 3.2, 95% CI 2.2-4.7). SIRS had similar implications when 
Sepsis-3 was used to determine organ dysfunction. SIRS was present in 1157 (75.4%) patients with 
(Sepsis-2) organ dysfunction and was associated with increased odds of mortality compared to the 
377 (24.6%) without SIRS (OR 1.8, 95% CI 1.2-2.7). Similarly, in those with Sepsis-3 organ dysfunction 
(n=1561 with SIRS and 605 without SIRS), SIRS was associated with increased odds of 30-day 
mortality (OR 2.2, 95% CI 1.5-3.1). However at one year, there was no association between SIRS and 
prognosis in patients with organ dysfunction according to either definition. In patients with shock, 
SIRS was present in 89% and not associated with increased mortality at either endpoint.  
 
Table 2 also allows comparison of sepsis subgroups according to Sepsis-2 and Sepsis-3 definitions 
(column 2). As defined in this study, patients with Sepsis-2 organ dysfunction comprised a subgroup 
of those with Sepsis-3 organ dysfunction. The 632 patients that met Sepsis-3 but not Sepsis-2 criteria 
for organ dysfunction presented with an acute increase in total SOFA of two or more, but that 
increase occurred in different organ systems. Mortality for those patients was significantly less than 
for those with Sepsis-2 organ dysfunction at 30 days (difference 3.6%, CI 0.8-6.4%), but not at one 
year (difference -2.6%, CI -6.8-1.5%). The relationship between study groups according to Sepsis-2 
and Sepsis-3 definitions are illustrated graphically in Figure 2. The last four rows of Table 2 and panel 
D in Figure 2 represent a potential compromise structure which recognises SIRS is associated with 
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increased mortality in patients without organ dysfunction but prognostically less important when 
organ dysfunction or shock is present.  
 
SIRS and qSOFA scores showed similar discrimination for Sepsis-3 organ dysfunction [area under 
receiver operating curves 0.72 vs 0.73, difference 0.01 (95% CI 0.0-0.03)] (Figure 3). A qSOFA score 
≥2 had high specificity for Sepsis-3 organ dysfunction but poor sensitivity [96.1% (95.7-96.6%) and 
29.9% (27.9-31.8%) respectively]. Specificity and sensitivity for SIRS≥2 were 61.1% (60.0-62.3%) and 
72.3% (70.3-74.1%). Supplementary Figure 1 shows results using the endpoint of 30-day mortality. 
 
Using Sepsis-2, the odds of mortality increased with greater number of organ system dysfunctions 
(Figure 4). Substantial variation was seen in the odds of mortality associated with dysfunction in 
individual organ systems (Table 3). Central nervous system (CNS) dysfunction was associated with 
the greatest mortality risk (OR 11.2, 95%CI 7.1-17.7), with haematological dysfunction the lowest 
and failing to achieve statistical significance (OR 1.6, 95%CI 0.9-2.9). E-Table 3 examines the 
implications of defining Sepsis-2 organ dysfunction at varying SOFA scores in each organ system. 
Mortality odds for each of the SIRS and qSOFA components are also presented in Table 3. Among 
these, altered conscious state was again the most powerful predictor.  
 
DISCUSSION 
In this large prospective study of ED patients with suspected infection of all severities, SIRS was 
found to be a useful marker of organ dysfunction and mortality, while the qSOFA had high specificity 
for organ dysfunction but poor sensitivity. Organ dysfunction was associated with 30-day mortality 
just over 10%, without significant difference between values obtained with Sepsis-2 and Sepsis-3. 
Using Sepsis-2, increasing number of discrete organ system dysfunctions increased mortality, but 
dysfunction in individual organ systems was associated with a wide variation in mortality risk.  
 
SIRS in the Emergency Department 
Previous investigators have found that SIRS is not useful for predicting which patients in hospital 
wards
9
 or the ED
16, 17 
have infection. While some components of SIRS may contribute to a clinician’s 
judgement regarding presence of infection, that assessment is ultimately based on a range of 
physiological, investigational and heuristic criteria, because a gold standard does not yet exist.  This 
paper examined the role of SIRS as a prognostic marker in ED patients with suspected infection. 
There are few previous studies with this aim. Shapiro and colleagues
18
 found no relationship 
between SIRS and mortality in ED patients with suspected infection without organ dysfunction (OR 
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0.8, 95%CI 0.4-1.6). The 3102 patients in that study were identified on the basis of blood culture 
request, and included patients discharged home from the ED. More recently, a larger Danish study
19
 
also used blood culture request to identify 5499 ED patients admitted with infection, and found SIRS 
associated with increased mortality (HR 1.5 95%CI 1.2-1.7). Marchik
20
 also found SIRS associated 
with significantly greater mortality in a cohort of 1031 ED patients with suspected infection (6.5% vs. 
1.4%, p = 0.02), but those investigators expanded SIRS criteria to include hyperglycaemia and altered 
mental state. Our study examined the largest prospective cohort of ED patients with suspected 
infection to date, and found SIRS associated with increased risk of organ dysfunction and mortality 
at 30 days and one year. The proposed Sepsis-3 definitions discarded SIRS and nominated organ 
dysfunction as an indicator of deleterious and dysregulated response to infection. Our results 
establish that SIRS is also associated with increased risk of deleterious response to infection and 
mortality. 
 
SIRS in patients with organ dysfunction 
Depending on method used, we found 24.6% (Sepsis-2) to 27.9% (Sepsis-3) of patients with organ 
dysfunction did not have SIRS. Other investigators have reported similar figures. 
18, 21, 22
 In our study, 
SIRS was associated with a modest increase in 30-day mortality risk in patients with infection and 
organ dysfunction, but this effect was not evident at one year. We could identify only one previous 
study designed to examine the prognostic effect of SIRS in ED patients with infection and organ 
dysfunction. In that study, Henriksen et al
22
 found SIRS was present in 75.8% of 1169 ED patients 
admitted with infection and organ dysfunction, and did not confer increased mortality risk (adjusted 
HR 1.17, 95% CI 0.84 to 1.64). Studies in ICU patients with infection have concluded SIRS adds little 
to prognosis in the context of organ dysfunction and shock.
12
 Kaukonen
10
 examined a large database 
of ICU patients with serious infection (mortality 23.4%), finding SIRS present in 87.9% and not 
associated with mortality in an adjusted analysis. In our study, patients with shock (mortality 23.8%) 
were SIRS-positive in 89%, with SIRS also not associated with mortality.  
 
Organ dysfunction 
Overall organ dysfunction according to both Sepsis-2 and Sepsis-3 provided similar estimates of 
mortality risk. The capacity to denote dysfunction in each of the six SOFA organ systems (Sepsis-2) 
allowed the identification of patients with dysfunction in multiple organ systems. This classification 
was important prognostically, with mortality increasing according to the number of organs affected, 
and could also provide relevant clinical information that may indicate requirement for particular 
interventions and organ support. Increasing mortality with cumulative organ dysfunction was also 
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observed in the Shapiro study
18
 although the criteria used to determine organ dysfunction were not 
SOFA-based. Our analyses found that mortality associated with each individual organ dysfunction 
varied widely (Table 3), despite the same SOFA threshold (increase by two or more) applying to 
each. E-Table 2 enables comparison of mortality in each organ system as the threshold is increased 
from one to four.  A CNS SOFA cut-off of one (any reduction in consciousness) is associated with 
outcomes similar to dysfunction in the other major organ systems. Furthermore, even at SOFA cut-
offs of 3 or more, gastrointestinal and hematological organ system dysfunction remains less 
important prognostically than dysfunction in other systems. The poor calibration of the SOFA score 
between organ systems seen in our study may be related to use in the ED setting and the fact that 
the SOFA score dates from 1996. Limitations in the SOFA score will also affect Sepsis-3 organ 
dysfunction criteria, and might be reduced by recalibrating the score with contemporary patient 
data. The 29% of patients with Sepsis-3 but not Sepsis-2 organ dysfunction presented with an 
increase in SOFA score by one in two or more different organ systems. Mortality in this group was 
less than with Sepsis-2 organ dysfunction at 30 days (but similar at one year), creating some 
uncertainty about whether these patients should be regarded to have organ dysfunction.  
 
SIRS and qSOFA 
The qSOFA score has been proposed as a parsimonious bedside tool to screen patients with infection 
for those at risk of organ dysfunction and death.
8
 Overall discrimination for organ dysfunction was 
similar for SIRS and qSOFA, but specificity and sensitivity differed at operating cutoffs of SIRS≥2 and 
qSOFA≥2. Despite qSOFA≥2 being highly specific for Sepsis-3 organ dysfunction and mortality (96.1% 
and 91.3% respectively), sensitivity was poor (29.7% and 49.1%) compared to sensitivity for SIRS≥2 
(72.1% and 76.7%). Given the relative insensitivity of qSOFA≥2, it appears inferior to SIRS≥2 as a 
screening test in the ED where the timely identification of high risk infected patients is paramount.  
 
Study limitations and strengths 
The methods used to identify patients may not have identified all ED patients admitted with 
infection, and not all included patients may have ultimately been shown to have infection. However 
it is likely that any method chosen to identify patients with infection of all severities in large enough 
numbers for meaningful analyses would have similar limitations. We aimed to minimise these issues 
by using a broad list of ED admission diagnoses indicating possible infection to screen for enrolment 
candidates, and only including those in whom ED and admitting teams concurred infection was the 
most likely cause for admission. Our methods were entirely observational and therefore data 
collected were limited to those generated in the course of standard investigation and treatment for 
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each patient. Despite this, missing data were minimal as reported. Our study was undertaken at a 
single centre, which may limit generalizability. We utilised a modified SOFA score for ED patients and 
this may influence the number of patients categorised with organ dysfunction. Derivation of the 
sepsis-3 sepsis criteria incorporated a secondary endpoint of mortality and/or ICU admission of ≥3 
days. Consistent with the primary endpoint of mortality, our analyses have assessed the 
performance of Sepsis-3 criteria against mortality at 30 days and one year but have not assessed this 
secondary endpoint. 
 
Strengths of our study include the prospective enrolment of a large cohort of ED patients admitted 
with suspected infection, and reliable short and long term mortality endpoints, sourced from a 
national database. Use of the SOFA score has enabled a comparison between alternative definitions 
for organ dysfunction in the context of infection, and ours is the first assessment of the proposed 
“Sepsis-3” criteria in the ED. 
 
Conclusions 
Our results indicate SIRS is a useful screening tool for organ dysfunction and death in ED patients 
with suspected infection. SIRS contributed less to prognosis in the context of organ dysfunction or 
shock, arguing against including SIRS as a requirement for entry into trials enrolling patients with 
severe sepsis and septic shock. Patients with organ dysfunction according to either Sepsis-2 or 
Sepsis-3 criteria had similar mortality. Reporting multiple organ dysfunctions (Sepsis-2) allows a 
description containing more prognostic and clinically relevant information. The wide variation in 
mortality risk associated with SOFA score of two in each organ system indicates the SOFA score may 
require calibration for use in the ED. 
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TABLES 
Table 1: Characteristics of the study cohort, by mortality at 30 days 
  Total Alive at 30 days  Deceased 30 days 
Entire cohort  8871 8544 (96.3%) 327 (3.7%) 
Males 4453 (51.3%) 4369 (51.1%) 184 (56.3%) 
Age in years - median (IQR) 49 (30-69) 47 (29-67) 79 (69-86) 
ED LOS in hours – median (IQR) 8.3 (5.5-12.2) 8.2 (5.4-12.2) 8.7 (6.0-12.0) 
Charlson score - median (IQR) 1 (0-3) 1 (0-3) 4 (2-6) 
Total SOFA – median (IQR) 1 (0-2) 1 (0-2) 5 (3-7) 
SIRS    
SIRS <2 4695 (52.9%) 4621 (54.1%) 74 (22.6%) 
SIRS ≥2 4176 (47.1%) 3923 (45.9%) 253 (77.4%) 
     SIRS leucocyte count 3933 (44.3%) 3726 (43.6%) 207 (63.3%) 
     SIRS temperature 2797 (31.5%) 2654 (31.1%) 143 (43.7%) 
     SIRS respiratory  2009 (22.5%) 1797 (21.0%) 212 (64.8%) 
     SIRS heart rate 4505 (50.8%) 4274 (50.0%) 231 (70.6%) 
qSOFA    
qSOFA <2 7966 (89.8%) 7803 (91.3%) 163 (49.8%) 
qSOFA ≥2 905 (10.2%) 741 (8.7%) 164 (50.2%) 
     GCS ≤13 454 (5.1%) 326 (3.8%) 128 (39.1%) 
     Respiratory rate ≥22 1868 (21.1%) 1667 (19.5%) 201 (61.5%) 
     SBP ≤100  2379 (26.8%) 2203 (25.8%) 176 (53.8%) 
SEPSIS-2 organ dysfunction    
No organ dysfunction 7337 (82.7%) 7201 (84.3%) 136 (41.6%) 
Organ dysfunction 1534 (17.3%) 1343 (15.7%) 191 (58.4%) 
       Cardiovascular  218 (2.5%) 166 (1.9%) 52 (15.9%) 
       Respiratory  779 (8.8%) 650 (7.6%) 129 (39.4%) 
       Renal  279 (3.1%) 214 (2.5%) 65 (19.9%) 
       Haematological  203 (2.3%) 189 (2.2%) 14 (4.3%) 
       Gastrointestinal  400 (4.5%) 375 (4.4%) 25 (7.6%) 
       Central nervous system  129 (1.5%) 86 (1.0%) 43 (13.1%) 
SEPSIS-3 organ dysfunction    
No organ dysfunction 6705 (75.6%) 6625 (77.5%) 80 (24.5%) 
Organ dysfunction 2166 (24.4%) 1919 (22.5%) 247 (75.5%) 
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IQR = inter-quartile range, ED LOS = Emergency Department length of stay, SIRS = systemic 
inflammatory response syndrome, SOFA = sequential organ function assessment, qSOFA = “quick” 
SOFA, GCS = Glasgow Coma Score, SBP = systolic blood pressure (mmHg). 
Table 2: Mortality for sepsis subgroups according to SEPSIS-2 and SEPSIS-3 and the prognostic 
impact of SIRS in patients with and without organ dysfunction. 
SIRS vs no SIRS: SIRS vs no SIRS: 
Classification Subgroup n =  
30-day 
mortality (%) 
Mortality 
difference 
Adjusted 
OR 
one year 
mortality (%) 
Mortality 
difference 
Adjusted 
OR 
SEPSIS-2                 
All SIRS<2 infection 4695 1.6 (1.2-2.0) 8.4 (7.6-9.2) 
No OD, SIRS≥2 sepsis 3019 3.2 (2.6-3.9) 2.3%                   
(1.6-2.9) 
3.2              
(2.2-4.7) 
11.2 (10.1-12.4) 4.2%                              
(2.5-5.5%) 
1.5                          
(1.2-1.7) No OD, SIRS<2 4318 0.9 (0.7-1.2) 7.0 (6.3-7.8) 
OD, SIRS≥2 severe sepsis 1157 13.6 (11.6-15.7)      4.6 %             
(1.1-8.1) 
1.8              
(1.2-2.7) 
26.1 (23.6-28.7)  2.5%                                   
(-2.5-7.5%) 
1.2                              
(0.9-1.7) OD, SIRS<2 377 9.0 (6.3-12.4) 23.6 (19.4-28.2) 
Shock, SIRS≥2 septic shock 194 23.7 (17.9-30.3) -1.3%                        
(-19.6-17.0) 
0.9             
(0.3-3.0) 
37.6 (30.8-44.9) -8.2%                                   
(-29.3-12.9%) 
0.7                       
(0.2-1.9) Shock, SIRS<2 24 25.0 (9.8-46.8)  45.8 (25.6-67.2) 
SEPSIS-3                 
No OD infection 6705 1.2 (0.9-1.5) 6.9 (6.3-7.6) 
No OD, SIRS≥2 2615 2.0 (1.5-2.6) 1.3%             
(0.7-1.9) 
2.8           
(1.8-4.5) 
8.6 (7.5-9.7) 2.7%              
(1.4-4.0) 
1.4             
(1.1-1.7) No OD, SIRS<2 4090 0.7 (0.5-1.0) 5.9 (5.2-6.7) 
OD sepsis 2166 11.4 (10.1-12.8) 26.3 (24.4-28.2) 
OD, SIRS≥2 1561 12.9 (11.3-14.6) 5.3%                 
(2.6-8.0) 
2.2           
(1.5-3.1) 
26.7 (24.5-29.0) 1.6%                    
(-2.5-5.7) 
1.2             
(1.0-1.6) OD, SIRS<2 605 7.6 (5.6-10.0) 25.1 (21.7-28.8) 
OD SEPSIS-3 but not SEPSIS-2 632 8.8 (6.8-11.3) 28.1 (24.6-31.8) 
COMBINATION                 
No OD, SIRS<2 infection 4318 0.9 (0.7-1.2) 7.0 (6.3-7.8) 
No OD, SIRS≥2 sepsis 3019 3.2 (2.6-3.9) 11.2 (10.1-12.4) 
OD (SEPSIS-2) severe sepsis 1534 12.5 (10.8-14.2) 25.5 (23.3-27.7) 
Shock septic shock 218 23.9 (18.4-30.1) 38.5 (32.0-45.3) 
 
SIRS = systemic inflammatory response syndrome, OD = organ dysfunction, OR = odds ratio, adjusted 
for age and co-morbidity (Charlson Score). Figures in parentheses are 95% confidence intervals. 
‘SEPSIS-2’ refers to established definitions
4
 and ‘SEPSIS-3’ to recently proposed definitions.
8
 
‘COMBINATION’ refers to a potential framework which recognises SIRS is associated with 
substantially increased mortality only in the absence of organ dysfunction.  
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Table 3: Mortality odds associated with individual SIRS and qSOFA criteria, and organ dysfunctions. 
SIRS criteria 
 n = 
OR 30-day mortality 
unadjusted 
OR 30-day mortality 
adjusted 
SIRS respiratory  2009  6.9 (5.5-8.7) 3.7 (2.9-4.8) 
SIRS heart rate 4505  2.4 (1.9-3.1) 2.7 (2.1-3.4) 
SIRS leucocyte count 3933  2.2 (1.8-2.8) 2.2 (1.7-2.8) 
SIRS temperature 2797  1.7 (1.4-2.2) 1.6 (1.3-2.0) 
qSOFA criteria    
GCS ≤13 454 16.2 (12.7-20.8) 8.7 (6.6-11.4) 
Respiratory rate ≥22 1868  6.6 (5.2-8.3) 3.6 (2.9-4.6) 
SBP ≤100 2379 3.4 (2.7-4.2) 3.3 (2.6-4.2) 
Organ system dysfunction    
Central nervous 129 14.9 (10.1-21.9) 11.2 (7.1-17.7) 
Cardiovascular 218 9.5 (6.8-13.3) 6.3 (4.3-9.1) 
Renal 279 9.7 (7.1-13.1) 4.6 (3.3-6.4) 
Respiratory 779 7.9 (6.3-10.0) 4.4 (3.4-5.7) 
Gastro-intestinal 400 1.8 (1.2-2.7) 1.9 (1.2-3.0) 
Haematological 203 2.0 (1.1-3.4) 1.6 (0.9-2.9) 
Organ system dysfunction was defined as increase in sequential organ function assessment (SOFA) 
score of 2 or more in a single organ system. Figures in parentheses are 95% confidence intervals. OR 
= odds ratio, with figures in final column adjusted for age and co-morbidity (Charlson Score). SIRS = 
systemic inflammatory response syndrome, qSOFA = “quick” SOFA, GCS = Glasgow Coma Score, SBP 
= systolic blood pressure (mmHg). 
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FIGURE LEGENDS 
Figure 1: Patient recruitment and classification according to SIRS and organ dysfunction. 
SIRS = systemic inflammatory response syndrome. Organ dysfunction (current definition or ‘Sepsis-
2’) is defined as an increase in sequential organ function assessment (SOFA) score of two or more, 
and shock as cardiovascular system organ dysfunction. 
 
 
Figure 2: Relationships between sepsis subgroups 
SIRS = systemic inflammatory response syndrome, SEPSIS-2 and SEPSIS-3 represent patients 
satisfying organ dysfunction criteria according to respective definitions. Respective ellipse areas are 
proportional according to the data. Panel A demonstrates SHOCK (cardiovascular dysfunction) being 
a subset of SEPSIS-2 organ dysfunction, which in turn is a subset of SEPSIS-3 organ dysfunction. Each 
of these groups contains patients with and without SIRS. Panel B represents established sepsis 
definitions
4
, with “sepsis” (infection + SIRS) in grey and “severe sepsis” (sepsis + organ dysfunction) 
cross-hatched. Panel C approximates the proposed Sepsis-3
8
 definitions, with “sepsis” (infection 
with organ dysfunction) in grey and “septic shock” cross-hatched. SIRS plays no role in this construct. 
Panel D represents a potential compromise, recognising SIRS is associated with increased mortality 
in the absence or organ dysfunction, and organ dysfunction (including shock) carries significant 
mortality risk regardless of SIRS criteria. 
 
 
Figure 3: Receiver operating curves for SIRS and qSOFA prediction of (Sepsis-3) organ dysfunction 
SIRS = systemic inflammatory response syndrome, qSOFA = “quick” sequential organ function 
assessment, AUC = area under curve, CI = confidence interval. Discrimination for SIRS and qSOFA 
were similar (AUC difference 0.01, 95%CI 0-0.03). Larger symbols indicate diagnostic characteristics 
for operating points SIRS≥2 and qSOFA ≥2. Using GCS≤14 rather than GCS≤13 in qSOFA increases 
AUROC to 0.76 (95%CI 0.75-0.77) with sensitivity 36.5% and specificity 95.4% (p<0.01 for both). 
 
 
Figure 4: 30-day mortality and adjusted odds ratio for mortality associated with organ dysfunction 
according to Sepsis-2 and Sepsis-3, and Sepsis-2 cumulative organ dysfunctions. 
Mortality = 30-day mortality (%), OR = odds ratio, adjusted for age and co-morbidity (Charlson Score) 
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Online supplements are not copyedited prior to posting and the author(s) take full responsibility for the accuracy of all data.  
e-Table 1: Modified sequential organ function assessment (SOFA) score 
 
SOFA = sequential organ function assessment, RESP = respiratory system, PaO2 = arterial oxygen partial 
pressure (mmHg), FiO2 = fraction inspired oxygen, SpO2 = oximetry saturation, RA = room air, CVS = 
cardiovascular system, SBP = systolic blood pressure (mmHg), NA = noradrenaline, HAEM = 
haematological system, GIT = gastrointestinal system, CNS = central nervous system, RENAL = renal 
system, Cr = creatinine, UO = urine output.  
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e-Table 2: Comparison of included and excluded presentations for the 618 patients with readmissions 
within 90 days. 
 
SIRS = systemic inflammatory response syndrome, qSOFA = “quick” sequential organ function 
assessment. In cases of readmissions within 90 days, a single admission was chosen at random from that 
period for inclusion. 472 patients had one representation excluded, 98 had 2 excluded, 27 had 3 excluded, 
and 19 had 4 or more excluded (total 846 excluded presentations). 429 patients had one representation 
included, 128 had 2 included, 41 had 3 included, and 18 patients had 4 or more representations included 
(total 884 included presentations) in the study dataset. 
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e-Table 3: Mortality and odds ratios for mortality using different SOFA cutoffs to denote organ 
dysfunction in different organ systems. 
 
SOFA = sequential organ function assessment, CVS = cardiovascular system, CNS = central nervous 
system, RESP = respiratory system, HAEM = haematological system, GIT = gastrointestinal system, 
RENAL = renal system, OR = (unadjusted) odds ratio. Table entries comprise number of patients with 
failure at each cut-off, 30-day mortality and OR for 30-day mortality with 95% confidence intervals in 
parentheses. 
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e-Figure 1: Receiver operating curves for SIRS and qSOFA prediction of 30-day mortality 
 
 
 
SIRS = systemic inflammatory response syndrome, qSOFA = “quick” sequential organ function 
assessment, AUC = area under curve, CI = confidence interval. 
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